147 related articles for article (PubMed ID: 35179304)
1. Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based study.
Liu L; Zhu J; Tian Y
Cancer Med; 2022 Jun; 11(11):2216-2223. PubMed ID: 35179304
[TBL] [Abstract][Full Text] [Related]
2. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Clinicopathological Characteristics and Prognosis of Patients with Nonurothelial Bladder Cancer.
Ren H; Wang K; Liu C
Arch Esp Urol; 2024 Mar; 77(2):148-157. PubMed ID: 38583007
[TBL] [Abstract][Full Text] [Related]
4. The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
Matulay JT; Woldu SL; Lim A; Narayan VM; Li G; Kamat AM; Anderson CB
Urol Oncol; 2019 Jun; 37(6):353.e17-353.e24. PubMed ID: 30704959
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis.
Jin D; Jin K; Qiu S; Zhou X; Yuan Q; Yang L; Wei Q
Cancer Med; 2020 Jul; 9(14):4897-4906. PubMed ID: 32529761
[TBL] [Abstract][Full Text] [Related]
6. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
[TBL] [Abstract][Full Text] [Related]
8. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.
Pan X; Yang W; Wen Z; Li F; Tong L; Tang W
J Gynecol Oncol; 2020 Nov; 31(6):e80. PubMed ID: 33078590
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.
Han Y; Wang J; Wang Z; Xu B
Cancer Control; 2021; 28():10732748211044355. PubMed ID: 34654324
[TBL] [Abstract][Full Text] [Related]
10. Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?
Mantica G; Chierigo F; Malinaric R; Smelzo S; Ambrosini F; Beverini M; Guano G; Caviglia A; Rigatti L; De Rose AF; Tafuri A; De Marchi D; Gaboardi F; Suardi N; Terrone C
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056397
[No Abstract] [Full Text] [Related]
11. Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
Rodler S; Buchner A; Ledderose ST; Eismann L; Volz Y; Pfitzinger P; Kretschmer A; Schulz GB; Karl A; Schlenker B; Stief CG; Jokisch F
World J Urol; 2021 Jul; 39(7):2537-2543. PubMed ID: 33084922
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of squamous histology in bladder cancer: a population-based study.
Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
[TBL] [Abstract][Full Text] [Related]
13. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
14. The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.
Antunes AA; Nesrallah LJ; Dall'Oglio MF; Maluf CE; Camara C; Leite KR; Srougi M
Int Braz J Urol; 2007; 33(3):339-45; discussion 346. PubMed ID: 17626650
[TBL] [Abstract][Full Text] [Related]
15. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder.
Gee JR; Montoya RG; Khaled HM; Sabichi AL; Grossman HB
Urol Oncol; 2003; 21(4):266-70. PubMed ID: 12954496
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.
Dotson A; May A; Davaro F; Raza SJ; Siddiqui S; Hamilton Z
Int J Clin Oncol; 2019 Jun; 24(6):706-711. PubMed ID: 30707342
[TBL] [Abstract][Full Text] [Related]
18. Does histology influence prognosis in patients with early-stage cervical carcinoma?
Grisaru D; Covens A; Chapman B; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2001 Dec; 92(12):2999-3004. PubMed ID: 11753977
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Race and Sex on Metastatic Bladder Cancer Survival.
Mahran A; Miller A; Calaway A; Prunty M; Arenas-Gallo C; Isali I; Ginsburg KB; Ponsky L; Markt S; Schumacher F; Bukavina L
Urology; 2022 Jul; 165():98-105. PubMed ID: 34813833
[TBL] [Abstract][Full Text] [Related]
20. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
